For the study, researchers surveyed 271 patients with medical marijuana prescriptions. Respondents were using marijuana for conditions such as chronic pain, mental health issues and gastrointestinal issues. Among these patients, 63 percent said they preferred using cannabis over their prescription drugs, which included opioids, benzodiazepines (sedatives) and antidepressants.
“Further research into how well cannabis works compared to the accepted front-line treatments is warranted,” said Zach Walsh, co-author of the study and an assistant professor in the department of psychology at the University of British Columbia. “Additionally, long-term research into the potential impact of the cannabis substitution on the quality of patient’s lives is ongoing.”
More articles on opioids:
Massachusetts governor cuts $150,000 in opioid abuse funds for Lynn
Large number of patients on anti-addiction medication may also have opioid prescription
Amid proposal to axe national drug policy office, advocates scramble to save it
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
